Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPM 962 vs ropinirole vs placebo in Parkinson's disease patients on L-dopa
jRCT2080220857Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rotigotine in Parkinson's disease (PD) (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080220857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220857.